Company Filing History:
Years Active: 2011
Title: Greg Fanning - Innovator in Gene Therapy
Introduction
Greg Fanning is a notable inventor based in Surry Hills, Australia. He has made significant contributions to the field of gene therapy, particularly in the area of hematopoietic progenitor cells. His work focuses on innovative methods that have the potential to transform treatment options for various diseases.
Latest Patents
Greg Fanning holds a patent for a process related to the preparation of a composition of genetically modified hematopoietic progenitor cells. This patent describes compositions and methods that pertain to gene therapy, specifically applied to hematopoietic progenitor cells. The invention emphasizes ex vivo gene therapy for the treatment or prevention of HIV infection, showcasing the potential for prolonged engraftment of modified hematopoietic cells in human subjects.
Career Highlights
Fanning is associated with Johnson & Johnson Research Pty Limited, where he continues to advance his research and innovations. His work has garnered attention for its implications in the medical field, particularly in improving therapeutic strategies for patients.
Collaborations
Throughout his career, Greg has collaborated with esteemed colleagues such as Geoffrey Phillip Symonds and Rafael G Amado. These partnerships have contributed to the development and refinement of his innovative approaches in gene therapy.
Conclusion
Greg Fanning's contributions to the field of gene therapy highlight his role as a pioneering inventor. His work not only advances scientific understanding but also holds promise for future medical applications.